PepsiCo posts better-than-expected second quarter despite lower US sales

PepsiCo exceeded Q2 revenue and adjusted EPS expectations, reporting $22.7 billion in revenue and $2.12 adjusted EPS, despite a 59% decline in net income. This beat was primarily driven by strong international sales, particularly in Latin America and Asia, and global demand for low/no-sugar Pepsi variants, which counteracted continued North American sales declines in snacks and beverages attributed to past price increases and shifting consumer preferences. The company is expanding value brand distribution to address domestic demand issues and reaffirmed its full-year guidance, which already incorporates rising tariff costs.

Analysis

PepsiCo demonstrated operational resilience in its second quarter, exceeding analyst expectations with revenue of $22.7 billion against a $22.3 billion forecast and an adjusted EPS of $2.12, surpassing the $2.03 consensus. This performance was primarily driven by strong international sales in regions like Latin America and Asia, along with robust global demand for low- and no-sugar beverage variants. However, this international strength masks significant underlying weakness in its core North American market, where Frito-Lay sales declined 1% and beverage sales fell 2%. The company attributes this domestic softness to weakened consumer demand following years of double-digit price increases. While adjusted earnings were strong, reported net income fell 59% to $1.3 billion, a decline attributed to one-time impairment charges on its Rockstar and Be & Cheery brands. Looking forward, PepsiCo reaffirmed its full-year guidance, which already accounts for headwinds including escalating tariff costs, such as the recent hike on imported aluminum from 25% to 50%. The company's strategy to counteract domestic price sensitivity by expanding value brands like Chester's and Santitas will be a key factor in its future performance.

Key Decisions for Investors

• Investors should weigh the company's proven ability to drive growth in international markets and healthier product segments against the persistent volume weakness in the core North American division.
• Monitor the effectiveness of the company's value-brand expansion strategy in North America as a key indicator of its ability to recapture price-sensitive consumers.
• Consider that while the earnings beat is positive, the reaffirmed guidance, ongoing tariff pressures, and significant impairment charges suggest a cautious outlook is warranted until a recovery in domestic sales volumes is evident.